Novartis Habitrol Will Be Relaunched for Combo Use By Grey
Executive Summary
Novartis is negotiating with FDA on Habitrol labeling revisions to include combination treatment with an undisclosed prescription product. Glaxo Wellcome's Zyban (bupropion), also indicated for smoking cessation, is a likely candidate.
You may also be interested in...
Glaxo Zyban/Wellbutrin DTC Accounts Move To Grey Advertising
The award of Glaxo's bupropion franchise to Grey Advertising consolidates six of the firm's nine DTC-advertised products into one agency.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011